Home  >  News
 Eppen_DNALoBind_Jun24
you can get e-magazine links on WhatsApp. Click here
News
  EPAM acquires Odysseus to transform the life sciences value chain with advanced analytics, data methods and AI,   June 17, 2024
  FOPE and PharmaState Academy ink MoU to enhance pharmaceutical workforce skillsets and capabilities,   June 17, 2024
  HCLTech, Olympus expand engineering and R&D partnership; to establish dedicated product innovation centre in Hyderabad,   June 13, 2024
  Kotak Alt invests Rs. 1,445 crore for acquisition of API business of Viatris by Matrix Pharma,   June 12, 2024
  Sova Health secures $1 million in seed round to accelerate growth of full stack gut health platform,   June 11, 2024
  Steadfast concerned on protein deficient population brings in fast-release supplements & multivitamin with plant extracts,   June 10, 2024
  Indoco Remedies receives US FDA tentative approval for canagliflozin and metformin hydrochloride tablets,   June 06, 2024
  Orchid Pharma gets DCGI approval to manufacture & market antibiotic drug combination of cefepime and enmetazobactam,   June 06, 2024
  Syngene launches platform for rapid, enhanced protein production,   June 05, 2024
  Lupin Atlantis Holdings completes acquisition of two brands from Sanofi in Europe & Canada,   June 05, 2024
  Aurigene opens biologics facility in Genome Valley for process development and clinical scale manufacturing capabilities,   June 04, 2024
  Lupin receives US FDA tentative approval for letermovir tablets,   June 03, 2024
  Tata Capital Healthcare Fund II invests upto $20 million in Orbicular Pharmaceutical Technologies,   June 03, 2024
  Supriya Lifescience unveils PAT growth of 32% in FY24, amidst 23.7% revenue surge,   June 01, 2024
  lndegene consolidated revenues clocks 12.3% growth YoY, crosses Rs. 2,589.6 crore PAT up by 26.5%,   May 30, 2024
  Alkem Labs net moves up to Rs. 304 crore in Q4, dividend at 250%,   May 30, 2024
  Piramal Pharma net jumps by 102% in Q4 to Rs. 101 crore,   May 30, 2024
  Zydus Lifesciences net jumps to Rs. 1,182 crore in Q4, dividend at 300%,   May 29, 2024
  AstraZeneca Pharma net profit grows to Rs. 39.5 crore in Q4FY24,   May 28, 2024
  Aurobindo Pharma net zooms by 79% in Q4 to Rs. 907 crore,   May 28, 2024

 Back
 
CPHISEA24
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram